ChemoPredict test
ChemoPredict assay
clinical guidelines
IVD test
validation studies of ChemoPredict
large clinical phase
diagnostics test
extended clinical validation strategy
high-risk breast cancer patients
breast cancer care
innovative predictive test
European market
highest clinical evidence level
detailed product development plan
primary breast cancer SIVIDON
detailed market analyses
market entrance
prototype diagnostic assay
best product development strategy
number of taxane
development strategies
analytical validation data
based chemotherapies
standard anthracycline-based chemotherapy
IVD directive
European countries
individualized tailoring of chemotherapy
elaborated business plan
specific use of taxanes
health care system
inclusion
costs
personalized medicine
trial
FinHer
test’s target group
reduction of overtreatment
reimbursement concepts
overall innovation project
effects
tool
opportunities
application
existing training
feasibility study
SIVIDON’s
prospective-retrospective approach
impairment of outcome
key opinion leaders
Advisory boards
objective
perspective
regimens
Regulatory issues